Journal: Current Diabetes Reviews Volume: 16 Issue: 3 Year: 2020 Page: 238-241 Author(s): Leandro B. Bergantin
Journal: Current Pharmaceutical Design Volume: 26 Issue: 27 Year: 2020 Page: 3326-3331 Author(s): Leandro B. Bergantin
Journal: Anti-Cancer Agents in Medicinal Chemistry Volume: 20 Issue: 7 Year: 2020 Page: 777-782 Author(s): Leandro B. Bergantin
Journal: Current Hypertension Reviews Volume: 16 Issue: 1 Year: 2020 Page: 73-78 Author(s): Leandro B. Bergantin
Journal: Current Medicinal Chemistry Volume: 19 Issue: 34 Year: 2012 Page: 5768-5773 Author(s): A. M. Hofer
Ebook: Frontiers in Clinical Drug Research - Alzheimer Disorders Volume: 7 Year: 2018 Author(s): Leandro Bueno Bergantin Doi: 10.2174/9781681085609118070007
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets Volume: 20 Issue: 3 Year: 2020 Page: 321-327 Author(s): Leandro B. Bergantin
Journal: Central Nervous System Agents in Medicinal Chemistry Volume: 20 Issue: 2 Year: 2020 Page: 103-109 Author(s): Leandro B. Bergantin
Journal: Current Molecular Medicine Volume: 4 Issue: 3 Year: 2004 Page: 263-275 Author(s): N. Macrez, J. Mironneau
Journal: Current Hypertension Reviews Volume: 15 Issue: 1 Year: 2019 Page: 32-39 Author(s): Leandro Bueno Bergantin
Previous Next